Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

135.00
Delayed Data
As of Jul 31
 -0.46 / -0.34%
Today’s Change
84.41
Today|||52-Week Range
137.50
+13.64%
Year-to-Date

Today’s Trading

Previous close135.46
Today’s open134.89
Day’s range133.02 - 136.00
Volume1,545,982
Average volume (3 months)1,548,416
Market cap$32.9B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-58.59%
Earnings growth (this year)+32.30%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)-52.11%
P/E ratioNM
Price/Sales48.16
Price/Book30.36

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC+0.77+0.40%
MYLMylan NV-0.36-0.64%
ZTSZoetis Inc+0.43+0.89%
BMRNBiomarin Pharmaceuti...+1.71+1.18%
Data as of 4:14pm ET, 07/31/2015

Financials

Next reporting dateOctober 26, 2015
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$580.4M
Annual profit (last year)-$738.6M
Net profit margin-127.09%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts